From a worldwide pandemic to geopolitical upheavals, disruption has become the new normal, and pharmaceutical leaders have recognized that the old ways of managing supply chains are no match for today’s business needs. Inflexible supply chains have exposed the pharmaceutical industry to delays and slowdowns in drug manufacturing and clinical trials as well as alarming shortages of life-saving medicines.
In response, pharmaceutical leaders now see digital transformation as a necessity. Watch the GEP-Pharma Manufacturing webcast Why Pharma Needs To Accelerate Digital Supply Chain Transformation Now, with GEP’s Pramod Sethumadhavan, senior director of consulting with GEP, and Pranav Padgaonkar, vice president of consulting, for a discussion about how digitalization can improve visibility, promote collaboration, and enable faster, better decisions based on real-time data — all to reach the goal of building greater resilience.
Key Discussion Points:
- How the drive toward lean supply chains has left the pharma industry prone to disruption
- What pharma leaders can gain from supply chain digitalization
- The digital essentials that can make supply chains more agile, resilient and higher-performing
Theme: Digital Transformation
RECOMMENDED
Featured
The Cost-Plus World of Supply Chains: The Macroeconomic and Geopolitical Environment
As geopolitical and macroeconomic concerns increase, this survey-based Economist Impact-GEP report looks at what companies are doing to manage the resultant supply chain challenges.
Webcast
The Pursuit of Supply Chain Resilience — Why Continuous, Ongoing and Effective Collaboration Is Key to Success
The last year has been difficult for supply chain professionals. Enterprises, governments and people were completely unprepared for the unprecedented scale and impact of the supply chain disruptions that ensued in the wake of COVID-19.
